http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015128849-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f708c06c41fb465fb25325f69c73f2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 2015-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f017d486b4c22bf61fd0aeb7fe691c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81df0c1281a60bf243cb307fefe999af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45221083ae274eea8bf0b81f06a9158d
publicationDate 2015-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015128849-A1
titleOfInvention Inhibition of the fractalkine-receptor interaction for the treatment of atopic dermatitis
abstract The invention relates to the treatment of atopic dermatitis through inhibition of the expression of fractalkine or of its receptor CX3CR1, or through inhibition of their interaction.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019014122-A1
priorityDate 2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005030245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1806145-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02076990-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0160406-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128778492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID186114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226449776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226449777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1712093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129760690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773

Total number of triples: 49.